Stock listing

Almirall Sa

Selected listing: E2Z · HAM · EUR · DE

Almirall Sa (Hamburg:E2Z), Health Technology. Latest release Oct 1, 2026: EADV 2026: Long-Term Disease Control for up to Five Years in Patients…

E2Z:HAMEURDEUpdated October 2, 2026

Ticker: Hamburg:E2Z
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Hamburg
Currency: EUR

About Almirall Sa

The company is focused on the research, development, and commercialization of innovative pharmaceutical products. Almirall aims to address unmet medical needs in dermatology and other therapeutic areas.

Latest news from Almirall Sa

EADV 2026: Long-Term Disease Control for up to Five Years in Patients With Moderate-to-Severe Atopic Dermatitis Treated With Lebrikizumab

October 1, 2026

Almirall Advances Skin Science and Shares New Evidence Across Its Dermatology Portfolio at EADV 2026

September 30, 2026

Almirall Enters Collaboration With CrystalO for the Discovery and Development of Novel Small Molecules in Medical Dermatology

August 10, 2026

Alantra Partners S A : Private Equity invests in Deudafix to build Southern Europe’s leading financial solutions platform for individuals

August 4, 2026

Almirall H1 2026 Results

July 24, 2026

All Almirall Sa news →

Events

Replays

Almirall, S.A. (ALMRY) Q2 2026 Earnings Call
Fri, Jul 24, 2026 · 04:00 AM ET
Watch
Almirall, S.A. (ALMRY) Q1 2026 Earnings Call
Mon, May 11, 2026 · 04:00 AM ET
Watch
Almirall, S.A. (ALMRY) Q4 2025 Earnings Call
Mon, Feb 23, 2026 · 04:00 AM ET
Watch